GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioGend Therapeutics Co Ltd (ROCO:6733) » Definitions » Deferred Policy Acquisition Costs

BioGend Therapeutics Co (ROCO:6733) Deferred Policy Acquisition Costs


View and export this data going back to 2019. Start your Free Trial

What is BioGend Therapeutics Co Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


BioGend Therapeutics Co (ROCO:6733) Business Description

Traded in Other Exchanges
N/A
Address
4th Floor, Number 3, Park Street, Nangang District, Taipei, TWN, 115
BioGend Therapeutics Co Ltd is a Taiwan based company involved in developing regenerative bio-orthopaedic medicine to advance the clinical science of maintaining healthy joints in skeletal system. The Company is primarily engaged in the research and development of bone medical device related products. Its products under development include Big-001, Big-006 and Big-009.